René Adam

Clinical/research background

René Adam is President of the Medical Board of the Paul Brousse Hospital, Villejuif, France and Head of the Oncological Surgery Unit of the Hepato Biliary Center at the hospital. Since 1994, he has held the position of Professor of Surgery at the Faculty of Medicine Kremlin Bicêtre at Paris South University, Paris.

Professor Adam’s main fields of activity and research are surgery of the liver, biliary tract and pancreas, and hepatic transplantation. He is particularly involved in the treatment of hepatocellular carcinoma and of liver metastases.

Professor Adam has been General Secretary and is currently Treasurer of the French Association of Surgery; he is a board member of the French Association of Hepato-Biliary Surgery and Liver Transplantation. He chairs the European Liver Transplant Registry and LiverMetsurvey, the international Registry of Colorectal liver metastases. He is on the Editorial Board of The Oncologist and member of several international societies, including the American Society of Clinical Oncology (ASCO), the European Society of Surgical Oncology (ESSO), the European Society of Organ Transplantation (ESOT), the European Surgical Association (ESA) and the International Hepato-Pancreatic and Biliary Association (IHPBA) .

Professor Adam has delivered more than 600 lectures on his research interests around the world, and has more than 200 publications in peer-reviewed journals.

Relevant peer-reviewed publications

1. Adam R, Pascal G, Azoulay D, Tanaka K, Castaing D, Bismuth H. Liver resection for colorectal metastases: the third hepatectomy. Annals of Surgery 2003 Dec;238(6):871-83; discussion 883-4.
2. Adam R, Del Gaudio M. Evolution of liver transplantation for hepatocellular carcinoma. Journal of Hepatology 2003 Dec;39(6):888-95.
3. Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, Samuel D, Bismuth H. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Annals of Surgery 2003 Oct;238(4):508-19
4. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, Levi F, Bismuth H. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Annals of Surgery 2004 Dec;240(6):1052-64.
5. Adam R. Improvement of survival by surgery in the treatment of hepatocellular carcinoma: evidence or non-evidenced-based? Annals of Surgical Oncology 2004 May;11(5):460-1. Epub 2004 Apr 12
6. Adam R, Lucidi V, Karam V. Liver transplantation in Europe: is there a room for improvement? Journal of Hepatology 2005 Jan;42(1):33-40.
7. Adam R, Aloia T, Krissat J, Bralet MP, Paule B, Giacchetti S, Delvart V, Azoulay D, Bismuth H, Castaing D. Is liver resection justified for patients with hepatic metastases from breast cancer? Annals of Surgery 2006 Dec;244(6):897-907; discussion 907-8
8. Adam R, Chiche L, Aloia T, Elias D, Salmon R, Rivoire M, Jaeck D, Saric J, Le Treut YP, Belghiti J, Mantion G, Mentha G; Association Francaise de Chirurgie. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Annals of Surgery 2006 Oct;244(4):524-35.
9. Adam R. Complete Pathological Response After Preoperative Chemotherapy For Colorectal Liver Metasstases: Myth Or Reality? Journal of Clinical Oncology 2008 Apr, 26(10) : 1635-41
10. Adam R, Wicherts DA, de Haas RJ, Ciacio O, Lévi F, Paule B, Ducreux M, Azoulay D, Bismuth H, Castaing Patients with initially unresectable colorectal liver metasstases is there a possibility of cure? DJ Clin Oncol. 2009 Apr 10;27(11):1829-3

Information submitted for ESCP Barcelona 2014